ReviewThe Journal of investigative dermatology2025
Emerging Roles of Ferroptosis in Skin Pathophysiology.
Review in The Journal of investigative dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease Pathways.International journal of molecular sciences · 2025Pooled it
- Inorganic materials to prevent liquefactive necrosis and improve wound healing: A role of infection control across ischemic models.Materials today. Bio · 2026Article
- Nitrogen Mustard Disrupts Bioenergetics and Activates Oxidative Stress-Induced Cell Death Pathways in Human Keratinocytes.Chemical research in toxicology · 2026Article
- Interaction of Ferroptosis and Immune-Mediated Inflammation in Psoriasis.Antioxidants (Basel, Switzerland) · 2026Review
- Targeting ferroptosis in osteoporosis: mechanisms and natural products therapies.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Programmed cell death (PCD) is a hallmark of tissue homeostasis and numerous human diseases. Ferroptosis, a more recently discovered type of PCD, is uniquely dependent on enzymatically driven accumulation of specific hydroperoxy-phospholipid species and iron-dependent reduction-oxidation (redox) dysregulation. Emerging evidence suggests that ferroptosis plays a critical role in the pathogeneses of several dermatologic disorders, including infections, malignancies, and chronic inflammatory and autoimmune diseases. In this study, we review relevant regulatory mechanisms of ferroptosis, illustrate the challenges faced by the studies of ferroptosis, and highlight ferroptosis vulnerabilities in the redox balance of the skin. Furthermore, we review the link between ferroptosis and skin immunosurveillance and discuss ferroptosis functions in select skin diseases. Additional mechanistic studies that link ferroptosis to dysregulated cellular metabolism and proliferation, inflammation, and carcinogenesis will accelerate the emergence of new preventative and therapeutic strategies across a variety of dermatologic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.